We've found
25,125
archived clinical trials in
Diabetes
We've found
25,125
archived clinical trials in
Diabetes
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
Updated: 12/31/1969
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
Updated: 12/31/1969
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
Updated: 12/31/1969
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
Updated: 12/31/1969
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
Updated: 12/31/1969
The Pilot Study:Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
Updated: 12/31/1969
The Pilot Study:Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Can Group Visits Improve Outcomes of Veterans With Diabetes
Updated: 12/31/1969
Can Group Visits Improve Outcomes of Veterans With Diabetes
Status: Enrolling
Updated: 12/31/1969
Can Group Visits Improve Outcomes of Veterans With Diabetes
Updated: 12/31/1969
Can Group Visits Improve Outcomes of Veterans With Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Can Group Visits Improve Outcomes of Veterans With Diabetes
Updated: 12/31/1969
Can Group Visits Improve Outcomes of Veterans With Diabetes
Status: Enrolling
Updated: 12/31/1969
Can Group Visits Improve Outcomes of Veterans With Diabetes
Updated: 12/31/1969
Can Group Visits Improve Outcomes of Veterans With Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy
Updated: 12/31/1969
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Add-on Study of MLR 1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy
Status: Enrolling
Updated: 12/31/1969
An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy
Updated: 12/31/1969
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Add-on Study of MLR 1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
Updated: 12/31/1969
Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics
Status: Enrolling
Updated: 12/31/1969
Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
Updated: 12/31/1969
Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin
Updated: 12/31/1969
Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin
Updated: 12/31/1969
Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
FreeStyle Libre Glucose Monitoring System in Pediatric Populations
Updated: 12/31/1969
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Status: Enrolling
Updated: 12/31/1969
FreeStyle Libre Glucose Monitoring System in Pediatric Populations
Updated: 12/31/1969
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
FreeStyle Libre Glucose Monitoring System in Pediatric Populations
Updated: 12/31/1969
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Status: Enrolling
Updated: 12/31/1969
FreeStyle Libre Glucose Monitoring System in Pediatric Populations
Updated: 12/31/1969
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
FreeStyle Libre Glucose Monitoring System in Pediatric Populations
Updated: 12/31/1969
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Status: Enrolling
Updated: 12/31/1969
FreeStyle Libre Glucose Monitoring System in Pediatric Populations
Updated: 12/31/1969
FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Use of CoG by Patients With Diabetes Mellitus
Updated: 12/31/1969
Evaluation of the CNOGA TensorTip COMBO GLUCOMETER (CoG) During Standardized Meal Test and Consecutive Home Use by Patients With Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Use of CoG by Patients With Diabetes Mellitus
Updated: 12/31/1969
Evaluation of the CNOGA TensorTip COMBO GLUCOMETER (CoG) During Standardized Meal Test and Consecutive Home Use by Patients With Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)
Updated: 12/31/1969
Impact of Nurse Case Management on Diabetes Co-morbidities
Status: Enrolling
Updated: 12/31/1969
DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)
Updated: 12/31/1969
Impact of Nurse Case Management on Diabetes Co-morbidities
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)
Updated: 12/31/1969
Impact of Nurse Case Management on Diabetes Co-morbidities
Status: Enrolling
Updated: 12/31/1969
DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)
Updated: 12/31/1969
Impact of Nurse Case Management on Diabetes Co-morbidities
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Role of Exenatide in Type 1 Diabetes
Updated: 12/31/1969
The Role of Exenatide in Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Role of Exenatide in Type 1 Diabetes
Updated: 12/31/1969
The Role of Exenatide in Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20
Updated: 12/31/1969
A Phase I, Randomized, Double-Blind Crossover Pharmacokinetic, Pharmacodynamic, and Safety Study of Subcutaneously Administered Humalog® (Insulin Lispro Injection; Rapid-Acting Insulin) With and Without Recombinant Human Hyaluronidase (rHuPH20) Versus Subcutaneously Administered Humulin R® (Regular Insulin Injection) With and Without rHuPH20
Status: Enrolling
Updated: 12/31/1969
Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20
Updated: 12/31/1969
A Phase I, Randomized, Double-Blind Crossover Pharmacokinetic, Pharmacodynamic, and Safety Study of Subcutaneously Administered Humalog® (Insulin Lispro Injection; Rapid-Acting Insulin) With and Without Recombinant Human Hyaluronidase (rHuPH20) Versus Subcutaneously Administered Humulin R® (Regular Insulin Injection) With and Without rHuPH20
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus
Updated: 12/31/1969
Phase II Study Evaluating Pharmacokinetics and Postprandial Glycemic Response of Subcutaneously Injected Humalog and Humulin R With/Without Co-Injected Recombinant Human Hyaluronidase Following Liquid Meal in Type1 Diabetes Mellitus Patients
Status: Enrolling
Updated: 12/31/1969
Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus
Updated: 12/31/1969
Phase II Study Evaluating Pharmacokinetics and Postprandial Glycemic Response of Subcutaneously Injected Humalog and Humulin R With/Without Co-Injected Recombinant Human Hyaluronidase Following Liquid Meal in Type1 Diabetes Mellitus Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
Updated: 12/31/1969
A Phase II, Randomized, Double Blind, 2-Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to Insulin Lispro (Humalog®) in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Virtual Visit for Women With Gestational Diabetes
Updated: 12/31/1969
The Virtual Visit for Women With Gestational Diabetes
Status: Enrolling
Updated: 12/31/1969
The Virtual Visit for Women With Gestational Diabetes
Updated: 12/31/1969
The Virtual Visit for Women With Gestational Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate Bacterial Activity That Drives the Progression of Clinical Infection
Updated: 12/31/1969
Study to Evaluate Bacterial Activity That Drives the Progression of Clinical Infection
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate Bacterial Activity That Drives the Progression of Clinical Infection
Updated: 12/31/1969
Study to Evaluate Bacterial Activity That Drives the Progression of Clinical Infection
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy
Updated: 12/31/1969
Prospective, Open-Label, Randomized, Controlled, Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy Using Dosage Recommending Device
Status: Enrolling
Updated: 12/31/1969
Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy
Updated: 12/31/1969
Prospective, Open-Label, Randomized, Controlled, Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy Using Dosage Recommending Device
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Improving Diabetes Control Through Peer Counseling and Incentives
Updated: 12/31/1969
Improving Diabetes Control Through Peer Counseling and Incentives
Status: Enrolling
Updated: 12/31/1969
Improving Diabetes Control Through Peer Counseling and Incentives
Updated: 12/31/1969
Improving Diabetes Control Through Peer Counseling and Incentives
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Updated: 12/31/1969
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ConnectedHeartHealth - Heart Failure Readmission Intervention
Updated: 12/31/1969
ConnectedHeartHealth - Heart Failure Readmission Intervention
Status: Enrolling
Updated: 12/31/1969
ConnectedHeartHealth - Heart Failure Readmission Intervention
Updated: 12/31/1969
ConnectedHeartHealth - Heart Failure Readmission Intervention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Infection Antibiotic Study
Updated: 12/31/1969
Surgical Management of Diabetic Foot Infections - The Role of Post-Operative Antibiotics
Status: Enrolling
Updated: 12/31/1969
Diabetic Foot Infection Antibiotic Study
Updated: 12/31/1969
Surgical Management of Diabetic Foot Infections - The Role of Post-Operative Antibiotics
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention Program
Updated: 12/31/1969
Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention (DPP) Program: a Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention Program
Updated: 12/31/1969
Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention (DPP) Program: a Randomized Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Digital Health Tool for Insulin Titration (DHIT) Individuals With Type 2 Diabetes: A Prospective Outcomes Study With a Retrospective Control Group
Updated: 12/31/1969
A Digital Health Tool for Insulin Titration (DHIT) for Individuals With Type 2 Diabetes: A Prospective Outcomes Study With a Retrospective Control Group.
Status: Enrolling
Updated: 12/31/1969
A Digital Health Tool for Insulin Titration (DHIT) Individuals With Type 2 Diabetes: A Prospective Outcomes Study With a Retrospective Control Group
Updated: 12/31/1969
A Digital Health Tool for Insulin Titration (DHIT) for Individuals With Type 2 Diabetes: A Prospective Outcomes Study With a Retrospective Control Group.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients
Updated: 12/31/1969
The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients
Status: Enrolling
Updated: 12/31/1969
The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients
Updated: 12/31/1969
The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Exploratory Placebo-Controlled Study of the Metabolic Effects of Two Medical Foods in Type 2 Diabetes
Updated: 12/31/1969
An Exploratory Placebo-Controlled Study to Evaluate the Metabolic Effects of Two Medical Food Products in Subjects With Type 2 Diabetes Treated With Diet and Exercise Alone or in Combination With Metformin ± Sulfonylurea
Status: Enrolling
Updated: 12/31/1969
Exploratory Placebo-Controlled Study of the Metabolic Effects of Two Medical Foods in Type 2 Diabetes
Updated: 12/31/1969
An Exploratory Placebo-Controlled Study to Evaluate the Metabolic Effects of Two Medical Food Products in Subjects With Type 2 Diabetes Treated With Diet and Exercise Alone or in Combination With Metformin ± Sulfonylurea
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Exploratory Placebo-Controlled Study of the Metabolic Effects of Two Medical Foods in Type 2 Diabetes
Updated: 12/31/1969
An Exploratory Placebo-Controlled Study to Evaluate the Metabolic Effects of Two Medical Food Products in Subjects With Type 2 Diabetes Treated With Diet and Exercise Alone or in Combination With Metformin ± Sulfonylurea
Status: Enrolling
Updated: 12/31/1969
Exploratory Placebo-Controlled Study of the Metabolic Effects of Two Medical Foods in Type 2 Diabetes
Updated: 12/31/1969
An Exploratory Placebo-Controlled Study to Evaluate the Metabolic Effects of Two Medical Food Products in Subjects With Type 2 Diabetes Treated With Diet and Exercise Alone or in Combination With Metformin ± Sulfonylurea
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Exploratory Placebo-Controlled Study of the Metabolic Effects of Two Medical Foods in Type 2 Diabetes
Updated: 12/31/1969
An Exploratory Placebo-Controlled Study to Evaluate the Metabolic Effects of Two Medical Food Products in Subjects With Type 2 Diabetes Treated With Diet and Exercise Alone or in Combination With Metformin ± Sulfonylurea
Status: Enrolling
Updated: 12/31/1969
Exploratory Placebo-Controlled Study of the Metabolic Effects of Two Medical Foods in Type 2 Diabetes
Updated: 12/31/1969
An Exploratory Placebo-Controlled Study to Evaluate the Metabolic Effects of Two Medical Food Products in Subjects With Type 2 Diabetes Treated With Diet and Exercise Alone or in Combination With Metformin ± Sulfonylurea
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials